Results for tag: "Panic Disorder Drug"

The Panic Disorder Drug market is a subset of the Mental Health market, focusing on the treatment of panic disorder. Panic disorder is a type of anxiety disorder characterized by recurrent, unexpected panic attacks, which are sudden periods of intense fear or discomfort. Common treatments for panic disorder include psychotherapy, cognitive-behavioral therapy, and medications such as selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines. The Panic Disorder Drug market is highly competitive, with a range of pharmaceutical companies offering various treatments. Companies in the market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. These companies are constantly researching and developing new treatments for panic disorder, as well as improving existing treatments. Show Less Read more